1. Home
  2. ABVC vs NOM Comparison

ABVC vs NOM Comparison

Compare ABVC & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • NOM
  • Stock Information
  • Founded
  • ABVC 2015
  • NOM 1993
  • Country
  • ABVC United States
  • NOM United States
  • Employees
  • ABVC N/A
  • NOM N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • NOM Investment Managers
  • Sector
  • ABVC Health Care
  • NOM Finance
  • Exchange
  • ABVC Nasdaq
  • NOM Nasdaq
  • Market Cap
  • ABVC 22.1M
  • NOM 24.4M
  • IPO Year
  • ABVC N/A
  • NOM N/A
  • Fundamental
  • Price
  • ABVC $3.39
  • NOM $10.75
  • Analyst Decision
  • ABVC
  • NOM
  • Analyst Count
  • ABVC 0
  • NOM 0
  • Target Price
  • ABVC N/A
  • NOM N/A
  • AVG Volume (30 Days)
  • ABVC 713.8K
  • NOM 6.9K
  • Earning Date
  • ABVC 08-13-2025
  • NOM 01-01-0001
  • Dividend Yield
  • ABVC N/A
  • NOM 3.39%
  • EPS Growth
  • ABVC N/A
  • NOM N/A
  • EPS
  • ABVC N/A
  • NOM N/A
  • Revenue
  • ABVC $508,383.00
  • NOM N/A
  • Revenue This Year
  • ABVC $735.18
  • NOM N/A
  • Revenue Next Year
  • ABVC N/A
  • NOM N/A
  • P/E Ratio
  • ABVC N/A
  • NOM N/A
  • Revenue Growth
  • ABVC 1904.43
  • NOM N/A
  • 52 Week Low
  • ABVC $0.40
  • NOM $8.52
  • 52 Week High
  • ABVC $5.48
  • NOM $10.48
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 58.50
  • NOM 55.60
  • Support Level
  • ABVC $3.30
  • NOM $10.50
  • Resistance Level
  • ABVC $3.92
  • NOM $11.22
  • Average True Range (ATR)
  • ABVC 0.65
  • NOM 0.26
  • MACD
  • ABVC -0.04
  • NOM 0.05
  • Stochastic Oscillator
  • ABVC 41.57
  • NOM 39.17

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About NOM Nuveen Missouri Quality Municipal Income Fund

Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.

Share on Social Networks: